Strategic Partnerships — Pharma-Biotech Collaborations: Optimizing Success, Minimizing Risk, and Maintaining Alignment (Spring Training Briefing Series)
Pittsburgh
Pharma and biotech companies continue to engage in collaborations in record-setting numbers. Potential collaboration partners often must contend with a complexity of issues within ever-faster time frames for completion. Big pharma's outward need for new product candidates and technologies is tempered by the inherent risks of new drug development and approval. This presentation will examine the concerns underlying key provisions in collaborative agreements and how these issues can be addressed in a win-win manner to keep both parties' interests aligned.
Presented by:
Morgan Lewis Partner Randall Sunberg
Agenda:
8:00am - 8:30am: Registration and breakfast
8:30am - 9:45am: Program
Location:
Pittsburgh Life Sciences Greenhouse
100 Technology Drive, Suite 400
Pittsburgh, PA 15219
RSVP to:
Steve Perdziola at 412.560.7786 or sperdziola@morganlewis.com
The Spring Training Briefing Series
Morgan Lewis, in cooperation with the Pittsburgh Life Sciences Greenhouse, has developed a series of practical, "from the dugout" briefings, exclusively for life sciences company executives in the Pittsburgh region. The Spring Training Series offers three monthly briefings, which will provide life sciences company executives with a solid grounding in the core issues, practical real-world examples, and a wealth of resource material. Briefings will be led by a lineup of Morgan Lewis partners, in concert with industry executives.
The Series:
- Effective Patent Strategies — Somewhere Between Prosecution and Litigation: An Introduction to Intellectual Property Diligence
- Regulatory Process — Navigating the FDA: Moving from Product Concept to Product Clearance/Approval
- Strategic Partnerships — Pharma-Biotech Collaborations: Optimizing Success, Minimizing Risk, and Maintaining Alignment